CHARLES COX: Open Payments
NPI 1982684361 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 10 payments from 7 companies in 2025. Trend: 2023 $74 · 2024 $39 · 2025 $1,039
Travel & lodging: $868Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| TELA Bio, Inc. | 1 | $868 |
| Novo Nordisk Inc | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| REVANCE THERAPEUTICS, INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex), Rybelsus, REXULTI, DAXXIFY, Wegovy, CAPLYTA, UBRELVY, Ozempic.
Industry payments across TN — which companies pay providers there.
